Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Primary Clarification Using Depth Filters in Bioreactor Operations – V 2.0

Posted on By


Biosimilars: SOP for Primary Clarification Using Depth Filters in Bioreactor Operations – V 2.0


Standard Operating Procedure for Primary Clarification Using Depth Filters in Bioreactor Operations for Biosimilars

Department Biosimilars
SOP No. SOP/BS/088/2025
Supersedes SOP/BS/088/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To describe the standardized procedure for primary clarification of harvested cell culture broth using depth filtration systems to remove cell debris and insoluble impurities prior to downstream purification in biosimilar manufacturing.

2. Scope

This SOP is applicable to all harvested mammalian cell culture broths within the biosimilar production facility undergoing depth filtration as the first clarification step post-centrifugation.

3. Responsibilities

  • Production Operator: Perform filter assembly, operation, and integrity checks.
  • Engineering Personnel: Calibrate and maintain filtration system hardware.
  • QA Officer: Review filter logs and validate compliance with GMP standards.

4. Accountability

The Production Manager is accountable for execution and verification of depth filtration operations and ensuring product is clarified as per specifications.

5. Procedure

5.1 Pre-Filtration Setup

  1. Ensure centrifuged harvest is transferred to the holding tank connected to the depth filter setup.
  2. Verify cleaning status of filtration skid and mark it “Cleaned and Ready.”
  3. Use pre-validated filter cartridges (e.g., Millistak+ HC or equivalent) based on process compatibility.

5.2 Filter Assembly and Integrity Check

  1. Install depth filter capsules into the housing with inlet/outlet direction as per flow arrow.
  2. Tighten housing clamps and check for leaks.
  3. Conduct pre-use water flush and integrity test as per manufacturer instructions.

5.3 Filtration Operation

  1. Start the peristaltic or diaphragm pump at low flow rate (~50 L/hr) and gradually increase to process rate (~200–500 L/hr).
  2. Maintain differential pressure within allowable range (e.g., <1.5 bar).
  3. Monitor turbidity of filtrate at periodic intervals using portable turbidimeter.
  4. Collect filtrate in pre-labeled clarified harvest tank.

5.4 Filter Changeover

  1. If differential pressure exceeds limit or flow drops significantly, initiate changeover.
  2. Record filter lot number, run time, volume processed, and reason for replacement in Annexure-1.
  3. Restart with new pre-sterilized filter module.

5.5 Post-Operation

  1. Perform post-use water flush and inspect filter housing for retained debris.
  2. Label used filters and dispose according to biohazard waste procedure (refer SOP/BS/048/2025).
  3. Record total volume filtered, filtrate turbidity, and final pressure in Annexure-1.

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • L/hr: Liters per Hour
  • µm: Micron

7. Documents

  1. Depth Filtration Log – Annexure-1

8. References

  • ICH Q7 – GMP for APIs
  • WHO TRS 999 – Biotech Production

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Depth Filtration Log

Date Batch No. Filter Lot No. Volume (L) Start Pressure (bar) End Pressure (bar) Remarks Operator
04/05/2025 BS-088-B03 DF-5247 480 0.4 1.3 Filter replaced after 480L Ajay Verma

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Incorporated filter integrity testing and turbidity monitoring steps Compliance with updated WHO GMP guidance
See also  Biosimilars: SOP for Transport of Cell Banks - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Elixir Department: SOP for Sampling from Storage Tank – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Formulation Development of Intraosseous Injections – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version